Japanese Biotech Stock News

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Sumitomo Metal Mining recently announced a second-quarter dividend increase to ¥65.00 per share, up from ¥49.00 a year ago, and revised its consolidated earnings guidance for the fiscal year ending March 31, 2026, expecting net sales of ¥1.55 trillion and profit attributable to owners of the parent of ¥74.00 billion. These updates signal management’s outlook on both business performance and shareholder returns, drawing attention to the company’s capital allocation priorities. With a boosted...

SWCC (TSE:5805) drew market attention after raising its full-year earnings guidance. The company pointed to higher operating profit in its Energy and Infrastructure division and stronger momentum across Communication, Mobility, and Semiconductor businesses. See our latest analysis for SWCC. SWCC’s momentum has been building, with the company’s recent guidance upgrade and dividend boost fueling a 50% share price return over the past month and a remarkable 47.6% total shareholder return over...

Kokusai Electric (TSE:6525) has just lowered its full-year earnings forecast for the period ending March 2026. The company cites delays in sales of certain NAND and DRAM equipment as the reason behind this downward revision. See our latest analysis for Kokusai Electric. Despite Kokusai Electric’s downward revision to its full-year outlook, the company’s momentum over the past year has been remarkable, with a 1-year total shareholder return of 94.45%. While the past month saw a 12.43% decline...

On November 7, 2025, Osaka Soda Co., Ltd. announced a share repurchase program of 5,000,000 shares (3.99% of outstanding shares) for ¥5,000 million, raised its full-year profit and dividend forecasts, and reported improved market conditions for key products. This combination of actions underlines the company’s focus on delivering higher shareholder returns and capital efficiency while adapting to evolving demand trends in its core chemical markets. We’ll examine how Osaka Soda’s new buyback...

Kajima Corporation recently raised its consolidated and non-consolidated earnings forecasts for the year ending March 31, 2026, and announced higher dividends for both the interim and full-year periods. The guidance revision reflects improved gross profit margins in Japan’s civil engineering and building construction businesses, with strong contributions from domestic subsidiaries and real estate operations. We’ll look at how Kajima’s improved forecast and dividend increase could influence...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

The board of IBJ, Inc. ( TSE:6071 ) has announced that it will be paying its dividend of ¥10.00 on the 30th of March...

Mazda Motor Corporation released consolidated earnings guidance for the fiscal year ending March 31, 2026, projecting net sales of ¥4.9 trillion and raising its year-end dividend forecast to ¥30 per share. This reinstatement of dividend guidance, after previously leaving it undecided, signals Mazda's emphasis on stable shareholder returns in response to current business performance. With the year-end dividend now set, we'll look at how Mazda's focus on steady returns shapes its...

On November 12, 2025, Japan Petroleum Exploration Co., Ltd. raised its full-year earnings guidance for the fiscal year ending March 31, 2026, citing higher-than-expected crude oil and natural gas sales prices, while also announcing a significant decrease in its interim dividend to ¥20.00 per share from ¥125.00 a year earlier. This marked revision highlights how commodity price movements can outweigh dividend policy shifts in influencing earnings outlooks for resource-focused companies. We'll...

Advantest (TSE:6857) recently took the stage at major industry conferences, where company leaders outlined how innovations in R&D, automation, and capacity expansion are shaping its response to the AI-driven shift in semiconductor demand. See our latest analysis for Advantest. Hot on the heels of those industry presentations, Advantest’s share price return has surged 123.98% since the start of the year. This reflects exceptional momentum and renewed optimism about its growth prospects. Over...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

With its stock down 20% over the past three months, it is easy to disregard Hanatour Japan (TSE:6561). But if you pay...

A lackluster earnings announcement from Fukuyama Transporting Co., Ltd. ( TSE:9075 ) last week didn't sink the stock...

Shareholders appeared unconcerned with Hakuhodo DY Holdings Inc's ( TSE:2433 ) lackluster earnings report last week. We...

Soracom, Inc.'s ( TSE:147A ) stock was strong after they recently reported robust earnings. However, we think that...

Investors appear disappointed with COVER Corporation's ( TSE:5253 ) recent earnings, despite the decent statutory...

Despite posting some strong earnings, the market for Seino Holdings Co., Ltd.'s ( TSE:9076 ) stock hasn't moved much...

Sumitomo Seika Chemicals Company, Limited.'s ( TSE:4008 ) recent soft profit numbers didn't appear to worry...

Appirits Inc.'s ( TSE:4174 ) investors are due to receive a payment of ¥14.00 per share on 13th of April. This will...

Nishimatsu Construction (TSE:1820) updated its earnings guidance for the year ending March 2026, revealing lower expected net sales because of overseas project delays. At the same time, improved profits from its real estate business are boosting the overall profit outlook. See our latest analysis for Nishimatsu Construction. After a generally steady run this year, Nishimatsu Construction’s latest guidance revision has injected some energy into the share price. The stock climbed 2.55% in the...

Ebrains, Inc. ( TSE:6599 ) just reported healthy earnings but the stock price didn't move much. We think that investors...

Investors were disappointed by SENKO Group Holdings Co., Ltd.'s ( TSE:9069 ) latest earnings release. We did some...

Ono Pharmaceutical (TSE:4528) and PRISM BioLab have reached a key milestone in their oncology research collaboration. PRISM received a milestone payment as their joint efforts, using PRISM's PepMetics platform, advanced potential clinical candidates. See our latest analysis for Ono Pharmaceutical. Ono Pharmaceutical’s collaboration success comes after several expansion moves, including opening a new European office, as investor optimism continues to build. The stock’s share price has surged...